BioMed Laboratory
 School of Life Sciences
 Nanjing University

Lab-Intro > Publications
Publications
  •   Identification of seven serum microRNAs from a genome-wide serum microRNA expression profile as potential noninvasive biomarkers for malignant astrocytomas. Yang C, Wang C, Chen X, Chen S, Zhang Y, Zhi F, Wang J, Li L, Zhou X, Li N, Pan H, Zhang J, Zen K, Zhang CY, Zhang C. Int J Cancer. 2013;132(1)
  •   Identification of seven serum microRNAs from a genome-wide serum microRNA expression profile as potential noninvasive biomarkers for malignant astrocytomas. Yang C, Wang C, Chen X, Chen S, Zhang Y, Zhi F, Wang J, Li L, Zhou X, Li N, Pan H, Zhang J, Zen K, Zhang CY, Zhang C. Int J Cancer. 2013;132(1)
  •   Low-molecular weight chitosan/vascular endothelial growth factor short hairpin RNA for the treatment of hepatocellular carcinoma. Huang Z, Dong L, Chen J, Gao F, Zhang Z, Chen J, Zhang J. Life Sci. 2012;91(23-24):1207-15.
  •   Low-molecular weight chitosan/vascular endothelial growth factor short hairpin RNA for the treatment of hepatocellular carcinoma. Huang Z, Dong L, Chen J, Gao F, Zhang Z, Chen J, Zhang J. Life Sci. 2012;91(23-24):1207-15.
  •   Preparation and antitumor activity of a polymeric derivative of methotrexate. Zhou, G., X. Cheng, S. Wu, X. Jiang, X. Shi, J. Chen, J. Zhang and J. Zhao. Am J Med Sci. 2012;344(4):294-299.
  •   Exogenous plant MIR168a specifically targets mammalian LDLRAP1: evidence of cross-kingdom regulation by microRNA. Zhang, L., D. Hou, X. Chen, D. Li, L. Zhu, Y. Zhang, J. Li, Z. Bian, X. Liang, X. Cai, Y. Yin, C. Wang, T. Zhang, D. Zhu, D. Zhang, J. Xu, Q. Chen, Y. Ba, J. Liu, Q. Wang, J. Chen, J. Wa
  •   miR-30 inhibits TGF-beta1-induced epithelial-to-mesenchymal transition in hepatocyte by targeting Snail1. Zhang, J., H. Zhang, J. Liu, X. Tu, Y. Zang, J. Zhu, J. Chen, L. Dong and J. Zhang. Biochem Biophys Res Commun. 2012;417(3):1100-1105.
  •   Locally instilled tumor necrosis factor-alpha antisense oligonucleotide inhibits allergic inflammation via the induction of Tregs. Luo, Y., Z. Pang, Q. Zhu, X. Cai, Y. Yin, M. Wang, J. Zhu, J. Chen, K. Zeng, C. Zhang and J. Zhang. J Gene Med. 2012;14(6):374-383.
  •   The effect of targeted delivery of anti-TNF-alpha oligonucleotide into CD169+ macrophages on disease progression in lupus-prone MRL/lpr mice. Huang, Z., Z. Zhang, Y. Zha, J. Liu, Y. Jiang, Y. Yang, J. Shao, X. Sun, X. Cai, Y. Yin, J. Chen, L. Dong and J. Zhang. Biomaterials. 2012;33(30):7605-7612.
  •   Targeted delivery of oligonucleotides into tumor-associated macrophages for cancer immunotherapy. Huang, Z., Z. Zhang, Y. Jiang, D. Zhang, J. Chen, L. Dong and J. Zhang. J Control Release. 2012;158(2):286-292.
  •   Preparation and antitumor activity of a polymeric derivative of methotrexate. Zhou, G., X. Cheng, S. Wu, X. Jiang, X. Shi, J. Chen, J. Zhang and J. Zhao. Am J Med Sci. 2012;344(4):294-299.
  •   Exogenous plant MIR168a specifically targets mammalian LDLRAP1: evidence of cross-kingdom regulation by microRNA. Zhang, L., D. Hou, X. Chen, D. Li, L. Zhu, Y. Zhang, J. Li, Z. Bian, X. Liang, X. Cai, Y. Yin, C. Wang, T. Zhang, D. Zhu, D. Zhang, J. Xu, Q. Chen, Y. Ba, J. Liu, Q. Wang, J. Chen, J. Wa
  •   miR-30 inhibits TGF-beta1-induced epithelial-to-mesenchymal transition in hepatocyte by targeting Snail1. Zhang, J., H. Zhang, J. Liu, X. Tu, Y. Zang, J. Zhu, J. Chen, L. Dong and J. Zhang. Biochem Biophys Res Commun. 2012;417(3):1100-1105.
  •   Locally instilled tumor necrosis factor-alpha antisense oligonucleotide inhibits allergic inflammation via the induction of Tregs. Luo, Y., Z. Pang, Q. Zhu, X. Cai, Y. Yin, M. Wang, J. Zhu, J. Chen, K. Zeng, C. Zhang and J. Zhang. J Gene Med. 2012;14(6):374-383.
  •   The effect of targeted delivery of anti-TNF-alpha oligonucleotide into CD169+ macrophages on disease progression in lupus-prone MRL/lpr mice. Huang, Z., Z. Zhang, Y. Zha, J. Liu, Y. Jiang, Y. Yang, J. Shao, X. Sun, X. Cai, Y. Yin, J. Chen, L. Dong and J. Zhang. Biomaterials. 2012;33(30):7605-7612.
  •   Targeted delivery of oligonucleotides into tumor-associated macrophages for cancer immunotherapy. Huang, Z., Z. Zhang, Y. Jiang, D. Zhang, J. Chen, L. Dong and J. Zhang. J Control Release. 2012;158(2):286-292.
  •   The effect of targeted delivery of anti-TNF-alpha oligonucleotide into CD169+ macrophages on disease progression in lupus-prone MRL/lpr mice. Huang Z, Zhang Z, Zha Y, Liu J, Jiang Y, Yang Y, Shao J, Sun X, Cai X, Yin Y, Chen J, Dong L, Zhang J. Biomaterials. 2012;33(30):7605-12.
  •   The effect of targeted delivery of anti-TNF-alpha oligonucleotide into CD169+ macrophages on disease progression in lupus-prone MRL/lpr mice. Huang Z, Zhang Z, Zha Y, Liu J, Jiang Y, Yang Y, Shao J, Sun X, Cai X, Yin Y, Chen J, Dong L, Zhang J. Biomaterials. 2012;33(30):7605-12.
  •   miR-30 inhibits TGF-beta1-induced epithelial-to-mesenchymal transition in hepatocyte by targeting Snail1. Zhang J, Zhang H, Liu J, Tu X, Zang Y, Zhu J, Chen J, Dong L, Zhang J. Biochem Biophys Res Commun. 2012;417(3):1100-5.
  •   miR-30 inhibits TGF-beta1-induced epithelial-to-mesenchymal transition in hepatocyte by targeting Snail1. Zhang J, Zhang H, Liu J, Tu X, Zang Y, Zhu J, Chen J, Dong L, Zhang J. Biochem Biophys Res Commun. 2012;417(3):1100-5.